Universal admission screening identifies C. auris colonization in patients, suggesting current criteria may miss at-risk individuals.
Universal admission screening for Candidozyma auris (C. auris) identified C. auris colonization in 25/22742 (0.1%) of patients. Most patients (20/25, 80%) did not meet public health screening criteria, suggesting known risk factors for C. auris may not sufficiently capture the impacted population. Findings may not be generalizable to higher-incidence settings.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: